These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18519723)

  • 21. Metallo-β-lactamase-production in meropenem-susceptible Pseudomonas aeruginosa isolates: risk for silent spread.
    Picão RC; Carrara-Marroni FE; Gales AC; Venâncio EJ; Xavier DE; Tognim MC; Pelayo JS
    Mem Inst Oswaldo Cruz; 2012 Sep; 107(6):747-51. PubMed ID: 22990963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
    Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
    Rodríguez-Martínez JM; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4783-8. PubMed ID: 19738025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    Hiraishi T; Miyata A; Takata T; Araake M; Ogawa H; Gotoh N; Nishino T
    Jpn J Antibiot; 2002 Feb; 55(1):67-76. PubMed ID: 11977922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
    Pillar CM; Torres MK; Brown NP; Shah D; Sahm DF
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4388-99. PubMed ID: 18779357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
    Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
    Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
    J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus.
    Hu ZQ; Zhao WH; Asano N; Yoda Y; Hara Y; Shimamura T
    Antimicrob Agents Chemother; 2002 Feb; 46(2):558-60. PubMed ID: 11796378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
    Wise R; Ashby JP; Andrews JM
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():233-8. PubMed ID: 2509417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of carbapenems on the transcriptional expression of the oprD, oprM and oprN genes in Pseudomonas aeruginosa.
    Kolayli F; Karadenizli A; Savli H; Ergen K; Hatirnaz O; Balikci E; Budak F; Vahaboglu H
    J Med Microbiol; 2004 Sep; 53(Pt 9):915-920. PubMed ID: 15314200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in
    Hassuna NA; Darwish MK; Sayed M; Ibrahem RA
    Infect Drug Resist; 2020; 13():285-293. PubMed ID: 32099420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity.
    Kessler RE; Fung-Tomc J; Kolek B; Minassian B; Huczko E; Gradelski E; Bonner DP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):380-5. PubMed ID: 7726502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Sumita Y; Mitsuhashi S
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):77-84. PubMed ID: 1864279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The postantibiotic effect of meropenem and imipenem on selected bacteria.
    Nadler HL; Pitkin DH; Sheikh W
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.